| For: | Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol 2015; 7(3): 425-442 [PMID: 25848468 DOI: 10.4254/wjh.v7.i3.425] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/425.htm |
| Number | Citing Articles |
| 1 |
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hiroshi Fukui, Hitoshi Yoshiji. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. International Journal of Molecular Sciences 2021; 22(13) doi: 10.3390/ijms22136921
|
| 2 |
Rizwana Hasan, Ashish Kumar, Sudeep Bose, Rahul Roy, Anil Arora, Praveen Sharma, Sai Pawan Nagumantri, Debarati Paul, Sangeeta Choudhury. Novel Microbial Signatures in the Faecal Microbiome Associated with Severe Alcoholic Hepatitis: Bacteroides Finegoldii and Veillonella Dispar. The Open Microbiology Journal 2023; 17(1) doi: 10.2174/18742858-v17-e230803-2023-7
|
| 3 |
Alessia Luzzi, Irene Maria Briata, Ilaria Di Napoli, Silvia Giugliano, Antonio Di Sabatino, Maria Rescigno, Hellas Cena. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome. Clinical Nutrition 2024; 43(6) doi: 10.1016/j.clnu.2024.04.032
|
| 4 |
Leonard Kaps, Carolina Medina-Montano, Matthias Bros, Stephan Grabbe, Simon Johannes Gairing, Eva M. Schleicher, Stephan Gehring, Jörn M. Schattenberg, Peter R. Galle, Marcus-Alexander Wörns, Michael Nagel, Christian Labenz, Tomasz Brzozowski. Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis. Mediators of Inflammation 2023; 2023 doi: 10.1155/2023/9930902
|
| 5 |
Lubomir Skladany, Tomas Koller, Michal Kukla, Katarina Soltys. Predictive, Preventive, and Personalised Medicine: From Bench to Bedside. Advances in Predictive, Preventive and Personalised Medicine 2023; 17 doi: 10.1007/978-3-031-34884-6_9
|
| 6 |
Rida Abid Hasan, Andrew Y. Koh, Ayesha Zia. The gut microbiome and thromboembolism. Thrombosis Research 2020; 189 doi: 10.1016/j.thromres.2020.03.003
|
| 7 |
Francesco Violi, Vittoria Cammisotto, Pasquale Pignatelli, Emanuele Valeriani. Gut Microbiota–Platelet Axis and Thrombosis in Advanced Chronic Liver Disease. Thrombosis and Haemostasis 2026; 126(05) doi: 10.1055/a-2628-4143
|
| 8 |
Majid Eslami, Ramtin Naderian, Mahdieh Tarahomi, Ali Babaeizad, Parya Amini, Pegah Pouya. Pharmacological Targets in Metabolic Diseases. 2026; doi: 10.1016/B978-0-443-27370-4.00026-3
|
| 9 |
Karlo Toljan, Bruce Vrooman. Psychoneuroimmunological approach to gastrointestinal related pain. Scandinavian Journal of Pain 2017; 17(1) doi: 10.1016/j.sjpain.2017.10.010
|
| 10 |
Panomwat Amornphimoltham, Peter S. T. Yuen, Robert A. Star, Asada Leelahavanichkul. Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis. Digestive Diseases and Sciences 2019; 64(9) doi: 10.1007/s10620-019-05581-y
|
| 11 |
|
| 12 |
Jing Yuan, Chen Chen, Jinghua Cui, Jing Lu, Chao Yan, Xiao Wei, Xiangna Zhao, NanNan Li, Shaoli Li, Guanhua Xue, Weiwei Cheng, Boxing Li, Huan Li, Weishi Lin, Changyu Tian, Jiangtao Zhao, Juqiang Han, Daizhi An, Qiong Zhang, Hong Wei, Minghua Zheng, Xuejun Ma, Wei Li, Xiao Chen, Zheng Zhang, Hui Zeng, Sun Ying, JianXin Wu, Ruifu Yang, Di Liu. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. Cell Metabolism 2019; 30(4) doi: 10.1016/j.cmet.2019.08.018
|
| 13 |
Dong-Yun Lee, Jung-Woo Shin, Yoon-Jung Shin, Seung-Won Han, Dong-Hyun Kim. Lactobacillus plantarum and Bifidobacterium longum Alleviate Liver Injury and Fibrosis in Mice by Regulating NF-κB and AMPK Signaling. Journal of Microbiology and Biotechnology 2024; 34(1) doi: 10.4014/jmb.2310.10006
|
| 14 |
Marwa Ahmed Meheissen. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2023; doi: 10.1007/978-3-031-08014-2_49
|
| 15 |
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 2023; 20(3) doi: 10.1038/s41575-022-00690-y
|
| 16 |
David Uihwan Lee, Greg Hongyuan Fan, Ryan Richard Ahern, Raffi Karagozian. The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011–2017 hospital data. European Journal of Gastroenterology & Hepatology 2021; 32(2) doi: 10.1097/MEG.0000000000001991
|
| 17 |
Yasushi Okura, Tadashi Namisaki, Shinya Sato, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Kenichiro Seki, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Yukihisa Fujinaga, Takuya Kubo, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Koh Kitagawa, Tsuyoshi Mashitani, Hiroyuki Ogawa, Koji Ishida, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatology Research 2019; 49(2) doi: 10.1111/hepr.13249
|
| 18 |
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher. The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021; 10(11) doi: 10.3390/cells10112959
|
| 19 |
Hui Huan, Tao Ren, Li Xu, Hong Hu, Chao Liu. Compositional distinction of gut microbiota between Han Chinese and Tibetan populations with liver cirrhosis. PeerJ 2021; 9 doi: 10.7717/peerj.12142
|
| 20 |
Muhammad Hassan, Richard Bakalov, Saiyara Baset, Pooja Shethna, Dhruti Patel, Andrea Weitoschova, Naqiyah Qadir, Raquel Batista. The Impact of Diet and Nutrition on the Gut-Liver Axis in Cirrhosis and Hepatic Encephalopathy. Journal of Biosciences and Medicines 2025; 13(10) doi: 10.4236/jbm.2025.1310022
|
| 21 |
Francesco Violi, Daniele Pastori, Pasquale Pignatelli, Vittoria Cammisotto. Endotoxemia and Platelets. JACC: Basic to Translational Science 2024; 9(3) doi: 10.1016/j.jacbts.2023.07.003
|
| 22 |
Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa, Masanori Furukawa, Shinya Sato, Hideto Kawaratani, Mitsuteru Kitade, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World Journal of Gastroenterology 2017; 23(47): 8355-8366 doi: 10.3748/wjg.v23.i47.8355
Abstract(1773) |
Core Tip(1587) |
Full Article(HTML)(8180)
|
Full Article (PDF)-1677K(1293)
|
Full Article (Word)-2672K(384)
|
Audio-2315K(90)
|
Videos (1-1)(20)
|
Peer-Review Report-133K(377)
|
Answering Reviewers-84K(403)
|
Supplementary Material-36K(434)
|
Times Cited (88)
|
Total Visits (10886)
|
Open
|
| 23 |
Chris Harlow, Merianne Mohamad, Jasmohan S. Bajaj, Luigi Nibali, Avijit Banerjee, Vishal C. Patel. Harnessing the oral microbiome in chronic liver disease: Mechanisms, therapeutic modulation and translational frontiers. Journal of Hepatology 2026; 85(2) doi: 10.1016/j.jhep.2026.04.023
|
| 24 |
Shiv K. Sarin, Ashok Choudhury. Acute-on-chronic liver failure: terminology, mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2016; 13(3) doi: 10.1038/nrgastro.2015.219
|
| 25 |
Edouard Roussel, Carole Brasse‐Lagnel, Jean‐Jacques Tuech, Helène Montialoux, Eloise Papet, Pauline Tortajada, Soumeya Bekri, Lilian Schwarz. Influence of Probiotics Administration Before Liver Resection in Patients with Liver Disease: A Randomized Controlled Trial. World Journal of Surgery 2022; 46(3) doi: 10.1007/s00268-021-06388-7
|
| 26 |
Shijin Hong, Shuai Li, Xiaoyan Meng, Ping Li, Xun Wang, Mengxiang Su, Xiaodong Liu, Li Liu. Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin. Acta Pharmaceutica Sinica B 2023; 13(1) doi: 10.1016/j.apsb.2022.06.010
|
| 27 |
Camila Matiollo, Elayne Cristina de Morais Rateke, Emerita Quintina de Andrade Moura, Michelle Andrigueti, Fernanda Cristina De Augustinho, Tamara Liana Zocche, Telma Erotides da Silva, Lenyta Oliveira Gomes, Mareni Rocha Farias, Janaína Luz Narciso-Schiavon, Leonardo Lucca Schiavon. Soluble Interleukin-1 Receptor Type 2 as a Marker of Inflammation and Disease Severity in Patients with Cirrhosis. GE - Portuguese Journal of Gastroenterology 2025; doi: 10.1159/000548717
|
| 28 |
Camila Marques de Alcântara Barreto, Eliane Almeida do Valle, Jessica Pronestino de Lima Moreira, Katia Farias e Silva, Siane Lopes Bittencourt Rosas, Patrícia Teixeira Santana, Ana Maria Pittella, Gustavo Pereira, Flavia Ferreira Fernandes, Renata de Mello Perez, Heitor Siffert Pereira de Souza. Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis. Annals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101567
|
| 29 |
Asiya Tafader, Jasmohan S. Bajaj. Present and future of fecal microbiome transplantation in cirrhosis. Liver Transplantation 2026; 32(1) doi: 10.1097/LVT.0000000000000542
|
| 30 |
Akika Fukawa, Shunsuke Baba, Kaori Iwasawa, Makoto Yamaguchi, Akira Hosono. Dietary α-Lactalbumin protects against thioacetamide-induced liver cirrhosis by maintaining gut-liver axis function in rats. Bioscience, Biotechnology, and Biochemistry 2020; 84(1) doi: 10.1080/09168451.2019.1660613
|
| 31 |
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra. Molecular Pathogenesis of NASH. International Journal of Molecular Sciences 2016; 17(9) doi: 10.3390/ijms17091575
|
| 32 |
Angela Horvath, Bettina Leber, Nicole Feldbacher, Markus Steinwender, Irina Komarova, Florian Rainer, Andreas Blesl, Vanessa Stadlbauer. The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59550-x
|
| 33 |
Hiroshi Fukui. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?. Inflammatory Intestinal Diseases 2016; 1(3) doi: 10.1159/000447252
|
| 34 |
Xia Niu, Ge Chang, Ning Xu, Rui Li, Bingyu Niu, Rui Mao, Shan Wang, Guiling Li, Jiandong Jiang, Lulu Wang. Vitamin A-Integrated Cinnamaldehyde Nanoemulsion: A Nanotherapeutic Approach To Counteract Liver Fibrosis via Gut–Liver Axis Modulation. ACS Nano 2025; 19(10) doi: 10.1021/acsnano.5c00136
|
| 35 |
Rolandas Gedgaudas, Jasmohan S Bajaj, Jurgita Skieceviciene, Greta Varkalaite, Gabija Jurkeviciute, Sigita Gelman, Irena Valantiene, Romanas Zykus, Andrius Pranculis, Corinna Bang, Andre Franke, Christoph Schramm, Juozas Kupcinskas. Circulating microbiome in patients with portal hypertension. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2029674
|
| 36 |
Tzu-Hao Li, Chih-Wei Liu, Chia-Chang Huang, Yu-Lien Tsai, Shiang-Fen Huang, Ying-Ying Yang, Chang-Youh Tsai, Ming-Chih Hou, Han-Chieh Lin. Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study. Journal of Clinical Medicine 2021; 10(11) doi: 10.3390/jcm10112244
|
| 37 |
Gursimran Singh, Shazia Ansari, Satyam Yadav, Khadga Raj Aran. Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications. Microbial Pathogenesis 2026; 211 doi: 10.1016/j.micpath.2025.108273
|
| 38 |
Ping Yi, Ming Zhao, Qianjin Lu. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. 2022; doi: 10.1007/978-981-19-1946-6_20
|
| 39 |
Qin Shi, Wei Wu, XiaoQin Sun, YingHai Liu, JingZheng Zeng, WeiQing Li, XueMei Dai, Gu Gong, QingQing Huang. Research progress on the interaction between multiple organ-brain axes and perioperative neurocognitive disorders: a narrative review. Frontiers in Aging Neuroscience 2025; 17 doi: 10.3389/fnagi.2025.1710009
|
| 40 |
Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sunil Kumar Mishra. Pathophysiological mechanisms underlying MAFLD. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(6) doi: 10.1016/j.dsx.2020.09.026
|
| 41 |
Qinglan Xia, Yumeng Lei, Jiadun Wang, Qiang Wang. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0741
|
| 42 |
Marian-Vlad Lăpădat, Claudia Georgeta Iacobescu, Ion Daniel Baboi, Maria Nedelcu, Lavinia Alice Bălăceanu, Valeria Ioana Grigorescu, Ion Dina. Gut Dysbiosis, Malnutrition and Sarcopenia in Liver Cirrhosis: A Narrative Review. Diseases 2026; 14(3) doi: 10.3390/diseases14030090
|
| 43 |
UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016; 4(5_suppl) doi: 10.1177/2050640616663689
|
| 44 |
Christian Niehaus, Daniel Geanon, Ayesha Lietzau, Marija Jankovic, Christopher Maucourant, Benjamin Maasoumy, Ernesto Sparrelid, Heiner Wedemeyer, Julia Kahlhöfer, Christine S. Falk, Itzel Medina Andrade, Andrea Ponzetta, Niklas K. Björkström, Anke R.M. Kraft, Markus Cornberg, Benedikt Strunz. Origin of Hypofunctional CD103+ NK Cells in Cirrhosis‐Associated Ascites. European Journal of Immunology 2025; 55(6) doi: 10.1002/eji.202451311
|
| 45 |
T. E. Polunina. Risk stratification in alcoholic cirrhosis of the liver: a case study. Meditsinskiy sovet = Medical Council 2023; (8) doi: 10.21518/ms2023-129
|
| 46 |
Melisa Dirchwolf, Andrés Eduardo Ruf. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World Journal of Hepatology 2015; 7(16): 1974-1981 doi: 10.4254/wjh.v7.i16.1974
|
| 47 |
Young-Kook Kim, Juhyun Song. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. Journal of Clinical Medicine 2021; 10(17) doi: 10.3390/jcm10173819
|
| 48 |
Hiroshi Fukui. Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?. World Journal of Gastroenterology 2015; 21(41): 11584-11596 doi: 10.3748/wjg.v21.i41.11584
|
| 49 |
Shiv Kumar Sarin, Ashok Choudhury. Acute-on-chronic Liver Failure. Current Gastroenterology Reports 2016; 18(12) doi: 10.1007/s11894-016-0535-8
|
| 50 |
Andrea Mancini, Francesca Campagna, Piero Amodio, Kieran M. Tuohy. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food & Function 2018; 9(3) doi: 10.1039/C7FO01528C
|
| 51 |
Juliette Mouries, Paola Brescia, Alessandra Silvestri, Ilaria Spadoni, Marcel Sorribas, Reiner Wiest, Erika Mileti, Marianna Galbiati, Pietro Invernizzi, Luciano Adorini, Giuseppe Penna, Maria Rescigno. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. Journal of Hepatology 2019; 71(6) doi: 10.1016/j.jhep.2019.08.005
|
| 52 |
Cui Zeng, Xinghuang Liu, Siran Zhu, Danping Xiong, Liangru Zhu, Xiaohua Hou, Kaifang Zou, Tao Bai. Resolvin D1 ameliorates hepatic steatosis by remodeling the gut microbiota and restoring the intestinal barrier integrity in DSS-induced chronic colitis. International Immunopharmacology 2022; 103 doi: 10.1016/j.intimp.2021.108500
|
| 53 |
Zhaoxi Zhang, Alice Pik-Shan Kong, Vincent Wai-Sun Wong, Hannah Xiaoyan Hui. Intermittent fasting and metabolic dysfunction-associated steatotic liver disease: the potential role of the gut-liver axis. Cell & Bioscience 2025; 15(1) doi: 10.1186/s13578-025-01406-w
|
| 54 |
Xin-yu Huang, Ying-hui Zhang, Shi-yu Yi, Lei Lei, Tao Ma, Rui Huang, Lan Yang, Zhen-mao Li, Di Zhang. Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1217338
|
| 55 |
Rebeca Pérez-Cabeza De Vaca, Balasubramaniyan Vairappan, Tomás Cortés Espinoza, Juan Antonio Suárez Cuenca, Cuauhtemoc Licona Cassani, Brenda Maldonado Arriaga, Chrisitan Navarro Gerrard, Diana Selene Morgan Penagos, Paul Mondragón Terán, Victoria Chagoya De Sanchez. Advances in Hepatology. 2021; doi: 10.5772/intechopen.96910
|
| 56 |
Laurent Grosse, Dmitry V. Bulavin. LSEC model of aging. Aging 2020; 12(11) doi: 10.18632/aging.103492
|
| 57 |
Rooshi Nathwani, Benjamin Mullish, David Kockerling, Alexander Cole, Nowlan Selvapatt, Ameet Dhar. Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use. European Medical Journal 2021; doi: 10.33590/emj/21-00026
|
| 58 |
Tao Zhang, Kewei Sun, Ya Wang, Lei Huang, Ren Lang, Wei Jiang. Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure. European Journal of Gastroenterology & Hepatology 2018; 30(2) doi: 10.1097/MEG.0000000000001026
|
| 59 |
Mohammad Mehdi Ommati, Omid Farshad, Khadijeh Mousavi, Akram Jamshidzadeh, Mohammadreza Azmoon, Sirus Heidari, Negar Azarpira, Hossein Niknahad, Reza Heidari. Betaine supplementation mitigates intestinal damage and decreases serum bacterial endotoxin in cirrhotic rats. PharmaNutrition 2020; 12 doi: 10.1016/j.phanu.2020.100179
|
| 60 |
Priyankar Dey. The role of gut microbiome in chemical-induced metabolic and toxicological murine disease models. Life Sciences 2020; 378 doi: 10.1016/j.lfs.2020.118172
|
| 61 |
Juan Lu, Chun-lei Chen, Jian-di Jin, Jun Chen, Cheng-bo Yu. Continuous elevation of procalcitonin in cirrhosis combined with hepatic carcinoma: a case report. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-020-05684-2
|
| 62 |
Yan-Chao Hu, Xiang-Chun Ding, Hui-Juan Liu, Wan-Long Ma, Xue-Yan Feng, Li-Na Ma. Effects of <i>Lactobacillus paracasei</i> N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis. World Journal of Gastroenterology 2024; 30(11): 1556-1571 doi: 10.3748/wjg.v30.i11.1556
|
| 63 |
Beatriz Garcia Mendes, Bernd Schnabl. From intestinal dysbiosis to alcohol-associated liver disease. Clinical and Molecular Hepatology 2020; 26(4) doi: 10.3350/cmh.2020.0086
|
| 64 |
Fatuma Meyer, Karen Bannert, Mats Wiese, Susanne Esau, Lea F. Sautter, Luise Ehlers, Ali A. Aghdassi, Cornelia C. Metges, Leif-A. Garbe, Robert Jaster, Markus M. Lerch, Georg Lamprecht, Luzia Valentini. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis. International Journal of Molecular Sciences 2020; 21(15) doi: 10.3390/ijms21155357
|
| 65 |
Liping Liu, Jiali Duan, Wangping He, Christian Waydhas. Gastrointestinal complications in intensive care. Medical Review 2025; 5(6) doi: 10.1515/mr-2025-0039
|
| 66 |
Duo Shen, Ling Sha, Ling Yang, Xuefeng Gu. Identification of multiple complications as independent risk factors associated with 1-, 3-, and 5-year mortality in hepatitis B-associated cirrhosis patients. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-10566-6
|
| 67 |
Md. Omar Faruk, Md. Kausar Uddin Ahmed, Nabila Ishrat, Sabrina Alam Mrittika, Md. Sakibul Alam, Md. Mahmudul Hasan, Farjana Afrin Tanjum, Nor Mohammad, Md. Ashiq Mahmud, Mohammad Nurul Amin. Liver cirrhosis: epidemiology, risk factors, potential complications, and possible treatment strategies. Gastroenterology & Endoscopy 2026; 4(2) doi: 10.1016/j.gande.2026.03.001
|
| 68 |
A. Horvath, B. Leber, B. Schmerboeck, M. Tawdrous, G. Zettel, A. Hartl, T. Madl, S. Stryeck, D. Fuchs, S. Lemesch, P. Douschan, E. Krones, W. Spindelboeck, F. Durchschein, F. Rainer, G. Zollner, R. E. Stauber, P. Fickert, P. Stiegler, V. Stadlbauer. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Alimentary Pharmacology & Therapeutics 2016; 44(9) doi: 10.1111/apt.13788
|
| 69 |
Chunwei Cheng, Jun Tan, Wei Qian, Lei Zhang, Xiaohua Hou. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction. Life Sciences 2018; 209 doi: 10.1016/j.lfs.2018.08.017
|
| 70 |
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee. Cirrhotic Cardiomyopathy. Current Gastroenterology Reports 2020; 22(9) doi: 10.1007/s11894-020-00783-1
|
| 71 |
Josip Stojic, Michał Kukla, Ivica Grgurevic. The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status. Diagnostics 2023; 13(18) doi: 10.3390/diagnostics13182960
|
| 72 |
Matthew J Rolph, Pompei Bolfa, Sarah M Cavanaugh, David Hilchie, Kerry E Rolph. Detection of intracellular bacteria in feline inflammatory cardiac, hepatic and renal diseases: a retrospective study using fluorescent in situ hybridisation. Journal of Feline Medicine and Surgery 2026; 28(3) doi: 10.1177/1098612X251396969
|
| 73 |
Yoo Li Lim, Moon Young Kim, Yoon Ok Jang, Soon Koo Baik, Sang Ok Kwon. Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study. Gut and Liver 2017; 11(5) doi: 10.5009/gnl16478
|
| 74 |
Garam An, Jisoo Song, Wei Ying, Whasun Lim. Overview of the hazardous impacts of metabolism-disrupting chemicals on the progression of fatty liver diseases. Molecular & Cellular Toxicology 2025; 21(2) doi: 10.1007/s13273-025-00521-6
|
| 75 |
Shen Jin, Aurelie Cenier, Daniela Wetzel, Bethlehem Arefaine, Mar Moreno-Gonzalez, Marilena Stamouli, Merianne Mohamad, Mariia Lupatsii, Emilio Ríos, Sunjae Lee, Ane Zamalloa, Shilpa Chokshi, Adil Mardinoglu, Saeed Shoaie, Naiara Beraza, Vishal C. Patel, Melanie Schirmer. Microbial collagenase activity is linked to oral–gut translocation in advanced chronic liver disease. Nature Microbiology 2025; 11(1) doi: 10.1038/s41564-025-02223-0
|
| 76 |
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9) doi: 10.3390/ijms22094495
|
| 77 |
Fangjia Zhao, Min Li, Mingyue Luo, Meng Zhang, Yahong Yuan, Haili Niu, Tianli Yue. The dose-dependent mechanism behind the protective effect of lentinan against acute alcoholic liver injury via proliferating intestinal probiotics. Food & Function 2024; 15(19) doi: 10.1039/D4FO02256D
|
| 78 |
Chun-Ze Zhou, Rui-Feng Wang, Wei-Fu Lv, Yu-Qin Fu, De-Lei Cheng, Yi-Jiang Zhu, Chang-Long Hou, Xian-Jun Ye. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. World Journal of Gastroenterology 2020; 26(24): 3472-3483 doi: 10.3748/wjg.v26.i24.3472
|
| 79 |
D. A. Kashtanova, O. N. Tkacheva. The phenomenon of intestinal permeability and its association with cardiovascular disease. Current status. Cardiovascular Therapy and Prevention 2020; 19(3) doi: 10.15829/1728-8800-2020-2474
|
| 80 |
Hiroshi Fukui, Reiner Wiest. Changes of Intestinal Functions in Liver Cirrhosis. Inflammatory Intestinal Diseases 2016; 1(1) doi: 10.1159/000444436
|
| 81 |
Enas M. Abo Eta, Wesam H. Amer, Mohamed E. Elhendawy, Fathia E. Asal. Spontaneous fungal peritonitis in cirrhotic Egyptian patients with ascites: a single-center study. Tanta Medical Journal 2024; 52(2) doi: 10.4103/tmj.tmj_7_24
|
| 82 |
Alexey A. Tinkov, Viktor A. Gritsenko, Margarita G. Skalnaya, Sergey V. Cherkasov, Jan Aaseth, Anatoly V. Skalny. Gut as a target for cadmium toxicity. Environmental Pollution 2018; 235 doi: 10.1016/j.envpol.2017.12.114
|
| 83 |
Zohaib Ahmed, Manesh Kumar Gangwani, Umair Iqbal, Amal Iqbal Kazi, Syeda Faiza Arif, Fnu Priyanka, Wade Lee-Smith, Muhammad Aziz, Fouad Jaber, Dushyant Singh Dahiya, Hassam Ali, Sumant Inamdar, Bradley Confer. Role of Rifaximin in the Prevention of Variceal Bleeding: Systematic Review and Meta-Analysis. American Journal of Therapeutics 2024; 31(4) doi: 10.1097/MJT.0000000000001712
|
| 84 |
Yuanqing Zhu, Wenkang Gao, Mingjian Cheng, Xuyang li, Kailin Cai, Liuying Chen, Huikuan Chu. Harnessing the power of the gut microbiome: a review of supplementation diagnosis and therapy for liver cirrhosis. Cellular and Molecular Life Sciences 2026; 83(1) doi: 10.1007/s00018-026-06098-0
|
| 85 |
Cui Zeng, Xinghuang Liu, Siran Zhu, Danping Xiong, Liangru Zhu, Xiaohua Hou, Kaifang Zou, Tao Bai. . 2021; doi: 10.2139/ssrn.3933601
|
| 86 |
Seiichi Ishida. Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies. Drug Metabolism and Pharmacokinetics 2018; 33(1) doi: 10.1016/j.dmpk.2018.01.003
|
| 87 |
Sang Hyuk Lee, Heon-Ju Kwon, Nam Hee Kim, Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Eun Hye Park, Byung Ik Kim. Bowel Wall Thickness, Elasticity, Intestinal Permeability, and Inflammatory Cytokines in Patients with Cirrhosis and Ascites. The Korean Journal of Medicine 2019; 94(6) doi: 10.3904/kjm.2019.94.6.511
|
| 88 |
Unnah Leitner, Anita Brits, Dawei Xu, Sasha Patil, Jing Sun. Efficacy of probiotics on improvement of health outcomes in cirrhotic liver disease patients: A systematic review and meta-analysis of randomised controlled trials. European Journal of Pharmacology 2024; 981 doi: 10.1016/j.ejphar.2024.176874
|
| 89 |
Michele Pier Luca Guarino, Michele Cicala, Lorenza Putignani, Carola Severi. Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota. World Journal of Gastroenterology 2016; 22(45): 9871-9879 doi: 10.3748/wjg.v22.i45.9871
|
| 90 |
Ruiyan Xu, Yifeng Yu, Tingtao Chen. Exploring the dark side of probiotics to pursue light: Intrinsic and extrinsic risks to be opportunistic pathogens. Current Research in Food Science 2025; 10 doi: 10.1016/j.crfs.2025.101044
|
| 91 |
Aanchal Bharti, Isar Sharma, Ritu Mahajan, Seema Langer, Nisha Kapoor. From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?). Indian Journal of Microbiology 2024; 64(3) doi: 10.1007/s12088-024-01267-w
|
| 92 |
Bahaa Eldeen Senousy Ismail, John M. Rivas, Xaralambos B. Zervos. Surgical Procedures on the Cirrhotic Patient. 2017; doi: 10.1007/978-3-319-52396-5_1
|
| 93 |
Suraphan Panyod, Wei-Kai Wu, Kuan-Hung Lu, Chun-Ting Liu, Yung-Lin Chu, Chi-Tang Ho, Wen-Luan Wendy Hsiao, Yi-Syuan Lai, Wei-Cheng Chen, Yu-En Lin, Shi-Hang Lin, Ming-Shiang Wu, Lee-Yan Sheen. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis Mice. Journal of Agricultural and Food Chemistry 2020; 68(10) doi: 10.1021/acs.jafc.9b07555
|
| 94 |
Makoto Usami, Makoto Miyoshi, Hayato Yamashita. Gut microbiota and host metabolism in liver cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11597-11608 doi: 10.3748/wjg.v21.i41.11597
|
| 95 |
Haiyan Shi, Longxian Lv, Hongcui Cao, Haifeng Lu, Ning Zhou, Jiezuan Yang, Haiyin Jiang, Huihui Dong, Xinjun Hu, Wei Yu, Xiawei Jiang, Beiwen Zheng, Lanjuan Li. Bacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4+ T cells in rats. Scientific Reports 2017; 7(1) doi: 10.1038/srep40516
|
| 96 |
Chien-Fu Hsu, Ming-Wei Lin, Chia-Chang Huang, Tzu-Hao Li, Chih-Wei Liu, Shiang-Fen Huang, Ying-Ying Yang, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin. Roles and mechanisms of circulating CEACAM1 in the cirrhosis-related intestinal hyperpermeability: in vitro approach. Journal of the Chinese Medical Association 2021; 84(9) doi: 10.1097/JCMA.0000000000000582
|
| 97 |
Alessandro Federico, Marcello Dallio, Justyna Godos, Carmela Loguercio, Federico Salomone. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. Translational Research 2016; 167(1) doi: 10.1016/j.trsl.2015.08.002
|
| 98 |
. 2020; doi: 10.70675/a3d3dfefzd83dz4502zb987z5b0a8fe8cff5
|
| 99 |
Ariel Aday, Jacqueline G. O’Leary. Acute on Chronic Liver Failure. Clinics in Liver Disease 2020; 24(3) doi: 10.1016/j.cld.2020.04.004
|
| 100 |
Marek Droździk, Stefan Oswald, Agnieszka Droździk. Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract. International Journal of Molecular Sciences 2020; 21(16) doi: 10.3390/ijms21165737
|
| 101 |
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8) doi: 10.26442/00403660.2021.08.200917
|
| 102 |
Irina Gîrleanu, Anca Trifan, Carol Stanciu, Cătălin Sfarti. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture. World Journal of Gastroenterology 2018; 24(39): 4419-4427 doi: 10.3748/wjg.v24.i39.4419
|
| 103 |
S. N. Mekhtiyev, O. A. Mekhtiyeva, O. M. Berko, A. M. Kolodkin. Role of increased intestinal permeability in the development and progression of liver diseases. Experimental and Clinical Gastroenterology 2023; (12) doi: 10.31146/1682-8658-ecg-220-12-130-139
|
| 104 |
|
| 105 |
Kangle Yang, Yaotian Peng, Lin Wang, Li Ren. Polymyxin B engineered polystyrene-divinylbenzene microspheres for the adsorption of bilirubin and endotoxin. RSC Advances 2021; 11(63) doi: 10.1039/D1RA06684F
|
| 106 |
Hiroshi Fukui. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update. Gut and Liver 2021; 15(5) doi: 10.5009/gnl20032
|
| 107 |
Daniela Machado, Diana Almeida, Catarina Leal Seabra, José Carlos Andrade, Ana Maria Gomes, Ana Cristina Freitas. Functional Bionanomaterials. Nanotechnology in the Life Sciences 2020; doi: 10.1007/978-3-030-41464-1_17
|
| 108 |
Beom Sun Chung, Keungmo Yang, Chihyun Park, Tom Ryu. Prolonged Intestinal Ethanol Absorption and Oxidative Stress: Revisiting the Gut–Liver Axis in Alcohol-Associated Disease. International Journal of Molecular Sciences 2025; 26(12) doi: 10.3390/ijms26125442
|
| 109 |
Henning Grønbæk, Sidsel Rødgaard-Hansen, Niels Kristian Aagaard, Vicente Arroyo, Søren K. Moestrup, Elisabet Garcia, Elsa Solà, Marco Domenicali, Salvatore Piano, Hendrik Vilstrup, Holger Jon Møller. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). Journal of Hepatology 2016; 64(4) doi: 10.1016/j.jhep.2015.11.021
|
| 110 |
Masanori Furukawa, Kei Moriya, Jiro Nakayama, Takako Inoue, Rie Momoda, Hideto Kawaratani, Tadashi Namisaki, Shinya Sato, Akitoshi Douhara, Kosuke Kaji, Mitsuteru Kitade, Naotaka Shimozato, Yasuhiko Sawada, Soichiro Saikawa, Hiroaki Takaya, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Junichi Yamao, Yasuhito Tanaka, Hitoshi Yoshiji. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis. Hepatology Research 2020; 50(7) doi: 10.1111/hepr.13509
|
| 111 |
Adina Ioana Mihele, Harrie Toms John, Nicoleta Negrut, Anca Ferician, Paula Marian, Felicia Manole. Hepatic Steatosis and Microbiota: A Regional Study on Patients from Western Romania. Gastrointestinal Disorders 2025; 7(1) doi: 10.3390/gidisord7010009
|
| 112 |
Fernando Magdaleno, Maximilian Joseph Brol, Robert Schierwagen, Frank Erhard Uschner, Michael Zwick, Jonel Trebicka. The Human Gut-Liver-Axis in Health and Disease. 2019; doi: 10.1007/978-3-319-98890-0_14
|
| 113 |
Wanting Yang, Gaoyue Guo, Chao Sun. Therapeutic potential of rifaximin in liver diseases. Biomedicine & Pharmacotherapy 2024; 178 doi: 10.1016/j.biopha.2024.117283
|
| 114 |
Haitao Shi, Lijuan Mao, Lianli Wang, Xiaojing Quan, Xiaoyu Xu, Yan Cheng, Shanshan Zhu, Fei Dai. Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2021; 33(1S) doi: 10.1097/MEG.0000000000002157
|
| 115 |
Jag Khalsa, Linda C. Duffy, Gabriela Riscuta, Pamela Starke‐Reed, Van S. Hubbard. Omics for Understanding the Gut‐Liver‐Microbiome Axis and Precision Medicine. Clinical Pharmacology in Drug Development 2017; 6(2) doi: 10.1002/cpdd.310
|
| 116 |
Mohammad Shafi Kuchay, Narendra Singh Choudhary, Bruno Ramos-Molina. Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease. American Journal of Physiology-Cell Physiology 2025; 328(5) doi: 10.1152/ajpcell.00951.2024
|
| 117 |
Joong-won Jeon, Nakwon Choi, Seung Hwan Lee, Jong Hwan Sung. Three-tissue microphysiological system for studying inflammatory responses in gut-liver Axis. Biomedical Microdevices 2020; 22(4) doi: 10.1007/s10544-020-00519-y
|
| 118 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Aliya Alieva, Ekaterina Kashuh, Ekaterina Tsvetaeva, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis. World Journal of Hepatology 2021; 13(5): 557-570 doi: 10.4254/wjh.v13.i5.557
|
| 119 |
Junwei Xiang, Zhengyan Zhang, Hongyi Xie, Chengcheng Zhang, Yan Bai, Hua Cao, Qishi Che, Jiao Guo, Zhengquan Su. Effect of different bile acids on the intestine through enterohepatic circulation based on FXR. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1949095
|
| 120 |
K V Zhdanov, S S Karyakin, K V Kozlov, D A Gusev, V S Sukachev, A V Saulevich, M V Yaremenko, S N Kizhlo, D M Shahmanov, D Yu Lobzin, M V Kurtukov, M A Dzheriev. Chronic hepatitis С and non-alcoholic fatty liver disease. Main aspects of pathogenesis. Bulletin of the Russian Military Medical Academy 2018; 20(1) doi: 10.17816/brmma12326
|
| 121 |
Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. Journal of Clinical and Experimental Hepatology 2020; 10(4) doi: 10.1016/j.jceh.2020.04.012
|
| 122 |
Claudia C. Alves, Dan L. Waitzberg, Laila S. de Andrade, Laís dos Santos Aguiar, Milene B. Reis, Camila C. Guanabara, Odair A. Júnior, Daniel A. Ribeiro, Priscila Sala. Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.02010
|
| 123 |
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?. Diseases 2019; 7(4) doi: 10.3390/diseases7040058
|
| 124 |
帆 蓝. The Mechanism of Portal Vein Thrombosis Combined with Liver Cirrhosis. Advances in Clinical Medicine 2025; 15(03) doi: 10.12677/acm.2025.153782
|
| 125 |
Seong-Yeop Jeong, Suna Kang, Cao Shi Hua, Zhang Ting, Sunmin Park. Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats. Genes & Nutrition 2017; 12(1) doi: 10.1186/s12263-017-0585-z
|
| 126 |
Linhao Zhang, Yang Tai, Shihang Tang, Chong Zhao, Huan Tong, Jinhang Gao, Chengwei Tang. Compromised Ileal Mucus Barrier Due to Impaired Epithelial Homeostasis Caused by Notch1 Signaling in Cirrhotic Rats. Digestive Diseases and Sciences 2021; 66(1) doi: 10.1007/s10620-020-06178-6
|
| 127 |
K L Bidne, M J Dickson, J W Ross, L H Baumgard, A F Keating. Disruption of female reproductive function by endotoxins. Reproduction 2018; 155(4) doi: 10.1530/REP-17-0406
|
| 128 |
Noriaki Oguri, Jun Miyoshi, Yuu Nishinarita, Haruka Wada, Nobuki Nemoto, Noritaka Hibi, Naohiro Kawamura, Sawako Miyoshi, Sonny T. M. Lee, Minoru Matsuura, Takako Osaki, Tadakazu Hisamatsu. Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model. npj Biofilms and Microbiomes 2024; 10(1) doi: 10.1038/s41522-024-00564-y
|
| 129 |
Steven L. Flamm, Kevin D. Mullen, Zeev Heimanson, Arun J. Sanyal. Rifaximin has the potential to prevent complications of cirrhosis. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818800307
|
| 130 |
Jiadi Wu, Daqiang Wu, Kelong Ma, Tianming Wang, Gaoxiang Shi, Jing Shao, Changzhong Wang, Guiming Yan. Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1/IL-1β signaling pathway. Journal of Leukocyte Biology 2020; 108(1) doi: 10.1002/JLB.3MA0120-325RR
|
| 131 |
Roberto Carnevale, Valeria Raparelli, Cristina Nocella, Simona Bartimoccia, Marta Novo, Anna Severino, Elena De Falco, Vittoria Cammisotto, Chiara Pasquale, Clara Crescioli, Antonio Sili Scavalli, Oliviero Riggio, Stefania Basili, Francesco Violi. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. Journal of Hepatology 2017; 67(5) doi: 10.1016/j.jhep.2017.07.002
|
| 132 |
Francesca Romana Ponziani, Maria Assunta Zocco, Lucia Cerrito, Antonio Gasbarrini, Maurizio Pompili. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Review of Gastroenterology & Hepatology 2018; 12(7) doi: 10.1080/17474124.2018.1481747
|
| 133 |
Wonchan Yoon, Hye-Bin Lee, Seong Un Jeong, Duyun Jeong, Miri Park, Sang Hoon Lee, Young-Soo Kim, Ho-Young Park. Effects of radish (Raphanus sativus) green extract on the intestinal mucus secretion and prebiotic activity. Journal of Functional Foods 2025; 131 doi: 10.1016/j.jff.2025.106956
|
| 134 |
Valeria Raparelli, Stefania Basili, Roberto Carnevale, Laura Napoleone, Maria Del Ben, Cristina Nocella, Simona Bartimoccia, Cristina Lucidi, Giovanni Talerico, Oliviero Riggio, Francesco Violi. Low‐grade endotoxemia and platelet activation in cirrhosis. Hepatology 2017; 65(2) doi: 10.1002/hep.28853
|
| 135 |
Anastasia Ntikoudi, Anastasia Papachristou, Alketa Spirou, Eleni Evangelou, Athanasios Tsartsalis, Eugenia Vlachou, George Mastorakos. Exploring the Role of Probiotics, Prebiotics, and Synbiotics in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease—A Scoping Review. Livers 2025; 5(3) doi: 10.3390/livers5030031
|
| 136 |
Yunhe Fu, Yuhong He, Kaihe Xiang, Caijun Zhao, Zhaoqi He, Min Qiu, Xiaoyu Hu, Naisheng Zhang. The Role of Rumen Microbiota and Its Metabolites in Subacute Ruminal Acidosis (SARA)-Induced Inflammatory Diseases of Ruminants. Microorganisms 2022; 10(8) doi: 10.3390/microorganisms10081495
|
| 137 |
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry. 2019; doi: 10.1016/B978-0-08-100596-5.21759-9
|
| 138 |
Eric K. Kwong, Huiping Zhou. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases. Liver Research 2019; 3(1) doi: 10.1016/j.livres.2019.02.003
|
| 139 |
Xin Chi, Calvin Q. Pan, Shunai Liu, Danying Cheng, Ziwen Cao, Huichun Xing, Alessandro Granito. Regulating Intestinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2020; 2020 doi: 10.1155/2020/6629196
|
| 140 |
Kelly A. Fader, Rance Nault, Dustin A. Ammendolia, Jack R. Harkema, Kurt J. Williams, Robert B. Crawford, Norbert E. Kaminski, Dave Potter, Bonnie Sharratt, Timothy R. Zacharewski. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice. Toxicological Sciences 2015; 148(2) doi: 10.1093/toxsci/kfv206
|
| 141 |
Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Lan Xintian. The gut-liver axis in fatty liver disease: role played by natural products. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1365294
|
| 142 |
Tongyao Wang, Xingyu Rong, Chao Zhao. Circadian Rhythms Coordinated With Gut Microbiota Partially Account for Individual Differences in Hepatitis B-Related Cirrhosis. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.936815
|
| 143 |
Yong-Tao Li, Jian-Rong Huang, Mei-Lian Peng, Andrea Mancuso. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/3743962
|
| 144 |
Thenappan Thenappan, Alexander Khoruts, Yingjie Chen, E. Kenneth Weir. Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension?. American Journal of Physiology-Heart and Circulatory Physiology 2019; 317(5) doi: 10.1152/ajpheart.00416.2019
|
| 145 |
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. Journal of Clinical and Translational Hepatology 2019; (X) doi: 10.14218/JCTH.2019.00035
|
| 146 |
Fanny Giron, Eamonn M M Quigley. Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective. Journal of Neurogastroenterology and Motility 2018; 24(3) doi: 10.5056/jnm18004
|
| 147 |
Kosuke Kaji, Soichiro Saikawa, Hiroaki Takaya, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Daisuke Kaya, Yuki Tsuji, Yasuhiko Sawada, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients. Antibiotics 2020; 9(4) doi: 10.3390/antibiotics9040145
|
| 148 |
Nasrin Mehranfard, Azadeh Yazdi, Asiye Rafiee Sardooi, Zeinab Shakerin, Maedeh Ghasemi. Honey protects against chronic unpredictable mild stress induced- intestinal barrier disintegration and hepatic inflammation. Molecular Biology Reports 2020; 47(11) doi: 10.1007/s11033-020-05888-4
|
| 149 |
Jennifer L Peng, Witina Techasatian, Takashi Hato, Suthat Liangpunsakul. Role of Endotoxemia in Causing Renal Dysfunction in Cirrhosis. Journal of Investigative Medicine 2020; 68(1) doi: 10.1136/jim-2019-001056
|
| 150 |
Marwa Ahmed Meheissen. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2022; doi: 10.1007/978-3-030-81303-1_49-1
|
| 151 |
Alfredo Papa, Paolo Santini, Sara Sofia De Lucia, Rossella Maresca, Angelo Porfidia, Pasquale Pignatelli, Antonio Gasbarrini, Francesco Violi, Roberto Pola. Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies. Thrombosis Research 2023; 232 doi: 10.1016/j.thromres.2023.11.005
|
| 152 |
Xia Wan, Hua Xu, Hu Li, Shan Zhong, Yu Lei, Huan Deng, Xiao Fu, Zhi Zhou. Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03910-2
|
| 153 |
Farhad Koohpeyma, Roozbeh Kiani, Morvarid Siri, Nima Montazeri-Najafabady, Zahra Moayedfard, Naeimehossadat Asmarian, Pooneh Mokarram, Negar Azarpira, Forough Saki, Mesbah Shams, Sanaz Dastghaib. Chlorella vulgaris and Lactobacillus casei Improve Liver Dysfunction via UPR and Autophagy in High-Fat Diet-Induced NAFLD in Mice. Probiotics and Antimicrobial Proteins 2026; 18(3) doi: 10.1007/s12602-025-10793-y
|
| 154 |
Na Young Lee, Ki Tae Suk. The Role of the Gut Microbiome in Liver Cirrhosis Treatment. International Journal of Molecular Sciences 2020; 22(1) doi: 10.3390/ijms22010199
|
| 155 |
Francesco Violi, Cristina Nocella. Editorial: Gut permeability-related endotoxemia and cardiovascular disease: A new clinical challenge. Frontiers in Cardiovascular Medicine 2023; 10 doi: 10.3389/fcvm.2023.1118625
|
| 156 |
Xiaofeng Cen, Wei Wang, Siyan Hong, Qin Wang, Na Wang, Ling Mo, Jingjing Li, Jingwen Li. Integrated microbiome and metabolomic analyses revealed the antifibrotic effect of vanillic acid on thioacetamide-induced liver fibrosis in mice. Food & Function 2024; 15(23) doi: 10.1039/D4FO02309A
|
| 157 |
Francesco Violi, Pasquale Pignatelli, Valentina Castellani, Roberto Carnevale, Vittoria Cammisotto. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis. Blood Reviews 2023; 57 doi: 10.1016/j.blre.2022.100998
|
| 158 |
Dae Sung Kim, Won Moon. Coagulopathy and platelet abnormalities in patients with inflammatory bowel disease. The Korean Journal of Internal Medicine 2025; 40(6) doi: 10.3904/kjim.2025.118
|
| 159 |
Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk. Diet-Regulating Microbiota and Host Immune System in Liver Disease. International Journal of Molecular Sciences 2021; 22(12) doi: 10.3390/ijms22126326
|
| 160 |
Jian-Xin Song, Lin Zhu, Chuan-Long Zhu, Jin-Hua Hu, Zi-Jian Sun, Xiang Xu, Min-You Xin, Qiong-Fang Zhang, Da-Zhi Zhang, Jia Shang, Jia-Quan Huang, Dong Xu. Acute Exacerbation of Chronic Hepatitis B. 2019; doi: 10.1007/978-94-024-1603-9_2
|
| 161 |
Atsushi Hosui, Takafumi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, Takuya Yamada, Naoki Hiramatsu. Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites. Journal of Clinical Medicine 2021; 10(2) doi: 10.3390/jcm10020294
|
| 162 |
Huizi Tan, Hong Yao, Shaoping Nie. Dietary Fiber, Gut Microbiota, and Health. 2025; doi: 10.1016/B978-0-443-21630-5.00003-4
|
| 163 |
I.G. Mustafin, T.E. Kurmanbaev, E.Yu. Yupatov, A.A. Erokhina, N.A. Maximova, R.M. Nabiullina, Z.R. Mukhametzyanova, M.D. Leonova. Role of lipopolysaccharide in the development of inflammation in placental tissue in preeclampsia. Russian Journal of Human Reproduction 2026; 32(2) doi: 10.17116/repro20263202197
|
| 164 |
Manisha Yadav, Smriti Verma, Purnima Tiwari, Madhav Nilakanth Mugale. Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives. Life Sciences 2024; 353 doi: 10.1016/j.lfs.2024.122934
|
| 165 |
Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. The role of the gut microbiota in the pathology and prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 60 doi: 10.1016/j.jnutbio.2018.03.006
|
| 166 |
Piotr Wosiewicz, Michał Żorniak, Marek Hartleb, Kamil Barański, Maciej Hartleb, Magdalena Onyszczuk, Joanna Pilch-Kowalczyk, Sławomira Kyrcz-Krzemień. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability. Clinics and Research in Hepatology and Gastroenterology 2016; 40(6) doi: 10.1016/j.clinre.2016.03.008
|
| 167 |
|
| 168 |
Veronika B. Dubinkina, Alexander V. Tyakht, Vera Y. Odintsova, Konstantin S. Yarygin, Boris A. Kovarsky, Alexander V. Pavlenko, Dmitry S. Ischenko, Anna S. Popenko, Dmitry G. Alexeev, Anastasiya Y. Taraskina, Regina F. Nasyrova, Evgeny M. Krupitsky, Nino V. Shalikiani, Igor G. Bakulin, Petr L. Shcherbakov, Lyubov O. Skorodumova, Andrei K. Larin, Elena S. Kostryukova, Rustam A. Abdulkhakov, Sayar R. Abdulkhakov, Sergey Y. Malanin, Ruzilya K. Ismagilova, Tatiana V. Grigoryeva, Elena N. Ilina, Vadim M. Govorun. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome 2017; 5(1) doi: 10.1186/s40168-017-0359-2
|
| 169 |
Ghaleb Oriquat, Amr Ali Mohamed Abdelgawwad El-Sehrawy, Waleed K. Abdulsahib, Wael Waleed Mustafa, S. Renuka Jyothi, Priya Priyadarshini Nayak, J. Bethanney Janney, Gurjant Singh, Aashna Sinha, Farzaneh Yazdi. Probiotic, synbiotic effects on the gut–liver axis: omics-enabled mechanisms and therapeutic windows. Future Microbiology 2026; 21(8) doi: 10.1080/17460913.2026.2684877
|
| 170 |
Tze Mun Loo, Fumitaka Kamachi, Yoshihiro Watanabe, Shin Yoshimoto, Hiroaki Kanda, Yuriko Arai, Yaeko Nakajima-Takagi, Atsushi Iwama, Tomoaki Koga, Yukihiko Sugimoto, Takayuki Ozawa, Masaru Nakamura, Miho Kumagai, Koichi Watashi, Makoto M. Taketo, Tomohiro Aoki, Shuh Narumiya, Masanobu Oshima, Makoto Arita, Eiji Hara, Naoko Ohtani. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity. Cancer Discovery 2017; 7(5) doi: 10.1158/2159-8290.CD-16-0932
|
| 171 |
George V. Tetz, Kelly V. Ruggles, Hua Zhou, Adriana Heguy, Aristotelis Tsirigos, Victor Tetz. Bacteriophages as potential new mammalian pathogens. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07278-6
|
| 172 |
Muzahir Hussain, Muhammad Umair Ijaz, Muhammad Ijaz Ahmad, Iftikhar Ali Khan, Syed Umar Farooq Bukhary, Waqar Khan, Sayed Hussain, Majid Suhail Hashmi, Chunbao Li. Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein diets. Food & Function 2020; 11(10) doi: 10.1039/D0FO02153A
|
| 173 |
Lijun Luo, Yongchun Chang, Li Sheng. Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective. Life Sciences 2023; 321 doi: 10.1016/j.lfs.2023.121614
|
| 174 |
Hiroshi Fukui. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms 2015; 3(4) doi: 10.3390/microorganisms3040759
|
| 175 |
Francesco Violi, Vittoria Cammisotto, Simona Bartimoccia, Pasquale Pignatelli, Roberto Carnevale, Cristina Nocella. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nature Reviews Cardiology 2023; 20(1) doi: 10.1038/s41569-022-00737-2
|
| 176 |
Murali Appukuttan, Senthil Kumar, Kishore Gurumoorthy Subramanya Bharathy, Vijay Kant Pandey, Viniyendra Pamecha. Impact of Functional Hepatic Venous Outflow Obstruction on Perioperative Outcome After Living-Donor Liver Transplant. Experimental and Clinical Transplantation 2019; 17(1) doi: 10.6002/ect.2017.0138
|
| 177 |
Wenjia Wang, Yiheng Han, Wen Yin, Qiaozhi Wang, Yi Wu, Maobo Du. Intestinal and hepatic benefits of BBR-EVO on DSS-induced experimental colitis in mice. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1428327
|